Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19

COVID-19 Clinical Trial

Official title:

Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04342806
• Other study ID #: Pro00105284
• Status: Completed
• Start date: April 10, 2020
• Est. completion date: September 30, 2022

Study information

• Verified date: August 2023
• Source: Duke University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The HERO Registry provides a resource for collecting information on Healthcare Workers (HCWs) currently working in the United States, and their families and communities. The overall goal of the Registry is to develop the infrastructure necessary to create and engage a community of people who may be eligible for participation in future research studies, including those of COVID-19 prophylaxis and treatment.

Description:

The HERO Registry provides a resource for collecting information on Healthcare Workers (HCWs) currently working in the United States, and their family members and communities. The overall goal of the Registry is to create and engage a community of HCWs and their families and communities who may be eligible for participation in future research studies, including those of COVID-19 prophylaxis and treatment. The HERO registry will create a repository of adults interested in COVID-19 research that can be eligible for future research studies. The main objectives of the study are 1) create a virtual community of adult HCWs in the United States, and their families and communities, 2) Identify adults interested in engaging in upcoming research studies, including those related to COVID-19, and 3) Create a dataset of health related measurements, risk factors, and outcomes for future analysis. The population of interest is adult healthcare workers in the United States, and their families and communities.

All analysis of the HERO Registry will be exploratory in nature. Analysis may include descriptive statistics of the cohort, statistical associations between variables of interest, and predictive modeling for health outcomes and behaviors. Analyses may be conducted on all participants in the HERO Registry or may be conducted on subpopulations defined based on clinical, demographic or other factors.

There is no direct benefit to the participants for their participation in this study, but the information obtained will be used in scientific research and may be helpful to the participant or others in the future. Participants may experience indirect benefits such as learning about their own health, access to health data, and opportunities to participate in future research.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 51466
• Est. completion date: September 30, 2022
• Est. primary completion date: September 30, 2022
• Gender: All
• Age group: 18 Years to 110 Years

Eligibility

Inclusion Criteria:

• A member of one of the following three groups:

• Individual currently works in a setting where individuals receive healthcare ("healthcare worker") (including emergency medical services), OR

• A family member of a healthcare worker, OR

• A member of a healthcare worker's community

• Age = 18

• Able to speak and read English or Spanish

Exclusion Criteria:

• There are no specific exclusion criteria for this study. Participants must meet inclusion criteria.

Related Conditions & MeSH terms

• COVID-19
• Health Care Worker (HCW)

Locations

Country	Name	City	State
United States	Duke Clinical Research Institute	Durham	North Carolina

Sponsors (2)

Lead Sponsor	Collaborator
Duke University	Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number and percent of participants who enroll in the HERO Registry Study by geographic region, age, COVID-19 risk factors, and past COVID-19 diagnosis		Up to 79 years
Primary	Distribution of COVID-19 risk factors by participant characteristics		Up to 79 years
Primary	Proportion of participants undergoing changes in health status (e.g. new diagnosis of COVID-19, ER visits, hospitalization)		Up to 79 years
Primary	Proportion of all participants enrolled in the HERO Registry who participate in an ancillary research study		Up to 79 years
Primary	Proportion of participants who continue to supply information about their health to the HERO Registry at various time points after their enrollment		Up to 79 years

External Links

•   Experiences of U.S. Nurses Compared With Nonnurses in the First Year of COVID-19: Findings From a National Registry
•   Gender and intention to leave healthcare during the COVID-19 pandemic among U.S. healthcare workers: A cross sectional analysis of the HERO registry
•   Impact of the Early Phase of the COVID-19 Pandemic on US Healthcare Workers: Results from the HERO Registry
•   Patterns of Potential Moral Injury in Post-9/11 Combat Veterans and COVID-19 Healthcare Workers
•   Racial/Ethnic Disparities in Healthcare Worker Experiences During the COVID-19 Pandemic: An Analysis of the HERO Registry